Business Standard

Sunday, December 22, 2024 | 09:47 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

High-stakes coronavirus vaccine rollout under spotlight amid challenges

The UK has ordered enough doses of the two-shot Pfizer-BioNTech vaccine to immunise 20 million people

Coronavirus, vaccine, covid, drugs, clinical trials
Premium

Britain will immunise people throughout the wider population next, based on age and risk.

James Paton and Naomi Kresge | Bloomberg
Now that Britain has become the first western country to approve a Covid-19 shot, the spotlight shifts to the high-stakes rollout. Vaccinating the country’s roughly 67 million people won’t happen overnight. The UK has ordered enough doses of the two-shot Pfizer-BioNTech vaccine to immunise 20 million people.

Who will get the vaccine first?

The government plans to prioritise as it begins to deploy the vaccine, starting with residents and staff in care homes, then moving to people over 80 years old and health-care workers, documents show.

Britain will immunise people throughout the wider population next, based on age and risk. The shot is

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in